| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 08/27/2008 | EP1959938A2 Matrix-controlled transdermal system comprising salts of ace inhibitor dicarboxylic acids |
| 08/27/2008 | EP1709066B1 Inclusion complexes of perindopril |
| 08/27/2008 | EP1697411A4 Process for purifying interferon beta |
| 08/27/2008 | EP1456394B1 Methods of using improved polymerases |
| 08/27/2008 | EP1156817B1 Controlling protein levels in eucaryotic organisms |
| 08/27/2008 | CN101249258A An uro-genital condition treatment system |
| 08/27/2008 | CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/26/2008 | US7417042 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 08/26/2008 | US7417030 Thrombolytic agents, restenosis, hypotension agents, heart failure, antiarrhythmia and -inflammation agents, angina, stroke, atherosclerosis, antiischemic agents, angiogenesis related disorders, anti carcinogenic and -tumor agents |
| 08/26/2008 | US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
| 08/26/2008 | US7417027 For decreasing food intake; eating disorders; sexual disorders |
| 08/26/2008 | US7417025 Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions |
| 08/26/2008 | US7417024 template-fixed beta -hairpin peptidomimetics incorporating a template-fixed chain of 7 or 11 alpha -amino acid residues which, depending on their position in the chain, are Gly, or Pro, or of certain types; inhibitors of various serine proteases such as trypsin, human cathepsin G, and thrombin |
| 08/21/2008 | WO2008098368A1 Inhibitors of hepatitis c ns3 protease |
| 08/21/2008 | WO2008098355A1 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 08/21/2008 | WO2008070347A3 Betulin-peptide conjugates |
| 08/21/2008 | US20080200511 Novel Compounds and Methods of Using the Same |
| 08/21/2008 | US20080200398 Compounds For Enzyme Inhibition |
| 08/21/2008 | US20080200397 dextrorotatory amino acids; vGek with Dval-gly-Dglu-Dlys as a central D-amino acid sequence; protect against amyloid-mediated neurotoxicity; have no similarities to the amino acid sequence in beta -amyloid regardless of the direction in which they are read |
| 08/21/2008 | US20080200396 Peptides or Peptidic Conjugate Derivatives of Msh and the Use Thereof for Cosmetically Fighting Against Canities |
| 08/21/2008 | US20080199454 Caspase inhibitor prodrugs |
| 08/21/2008 | US20080199436 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers |
| 08/21/2008 | CA2676297A1 Inhibitors of hepatitis c ns3 protease |
| 08/20/2008 | EP1958956A2 Peptidomimetic protease inhibitors |
| 08/20/2008 | EP1957516A2 Alfa-helix mimetics and method relating to the treatment of cancer stem cells |
| 08/20/2008 | EP1428530B1 Tetrapeptide derivative crystals |
| 08/20/2008 | EP1345955B1 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release |
| 08/20/2008 | CN101248083A NOGO receptor polypeptides and polypeptide fragments and uses thereof |
| 08/20/2008 | CN101245097A Inhibitors of serine proteases, particular hcv NS3-NS4 protease |
| 08/20/2008 | CN101245096A Liquid phase synthesizing method for N-benzyl oxylcarbonyl isoleucyl ¿Cbeta-tert-butyl glutamyl-alanyl-amino aldehyde |
| 08/20/2008 | CN101245094A Liquid phase synthesizing method of peptide aldehyde |
| 08/20/2008 | CN100412087C Sequence number2 bioactive peptide |
| 08/19/2008 | US7414139 Catalytic antioxidants and methods of use |
| 08/19/2008 | US7414108 novel prostatic acid phosphatase and corresponding coding region derived from mouse; immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation. |
| 08/19/2008 | US7414107 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 08/19/2008 | US7414023 polypeptides/peptidomimetics; solid phase synthesis; for use in diagnositc assays |
| 08/19/2008 | US7413538 Epitopes formed by non-covalent association of conjugates |
| 08/16/2008 | CA2579119A1 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 08/14/2008 | WO2008097676A1 Compounds and compositions as channel activating protease inhibitors |
| 08/14/2008 | WO2008097673A1 Compounds and compositions as channel activating protease inhibitors |
| 08/14/2008 | WO2008095999A1 Pyrimidine substituted macrocyclic hcv inhibitors |
| 08/14/2008 | WO2008033557A3 Click chemistry-derived cyclic peptidomimetics as integrin markers |
| 08/14/2008 | WO2007146269A3 Peptide fragments for inducing synthesis of extracellular matrix proteins |
| 08/14/2008 | WO2007134384A3 Selective modulation of receptor signalling |
| 08/14/2008 | US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia |
| 08/14/2008 | US20080193983 Quasirandom Structure and Function Guided Synthesis Methods |
| 08/14/2008 | CA2677487A1 Compounds and compositions as channel activating protease inhibitors |
| 08/14/2008 | CA2677485A1 Compounds and compositions as channel activating protease inhibitors |
| 08/13/2008 | EP1678196B1 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) |
| 08/13/2008 | EP1483290B1 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 08/13/2008 | CN101242816A HCV inhibitors |
| 08/13/2008 | CN101240017A A uro-genital disease treatment system |
| 08/13/2008 | CN101240016A Shark protein antihypertensive peptide and preparation method and application thereof |
| 08/13/2008 | CN100410276C Polypeptide |
| 08/12/2008 | US7411055 Genetic engineering |
| 08/12/2008 | US7410962 Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
| 08/12/2008 | US7410956 Caspase inhibitor prodrugs |
| 08/12/2008 | US7410951 derivatives of Hemiasterlin or Geodiamolide G; pyrido(3,4-B)indole amides; extraction from marine sponges; anti-mitotic and carcinogenic agent; cause mitotic arrest and produce abnormal mitotic spindles |
| 08/12/2008 | US7410950 Peptides of CaV2.2 that inhibit pain |
| 08/12/2008 | US7410806 Screening for agents that inhibit complex formation using competitive binding assay based on fluorescence depolarization or internal energy transfer; antiinflammatory |
| 08/12/2008 | US7410777 Continously induced g-protein coupled receptors; membrane binding assays |
| 08/07/2008 | WO2008092281A1 Template-fixed peptidomimetics |
| 08/07/2008 | WO2008057235A3 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes |
| 08/07/2008 | WO2007127290A3 Method for producing viral vaccine and therapeutic peptide antigens |
| 08/07/2008 | WO2007076322A8 Compositions and methods for attenuating mitochondria-mediated cell injury |
| 08/07/2008 | US20080188378 Novel variants of the PapM polypeptide of bacteria of the streptomyces genus |
| 08/07/2008 | US20080187994 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; immunotherapy |
| 08/07/2008 | US20080187980 Interleukin-1b converting enzyme protein crystal for use in designing drugs which target and treat cell proliferative, autoimmune, nervous system and ischemic disorders |
| 08/07/2008 | CA2676865A1 Template - fixed peptidomimetics |
| 08/07/2008 | CA2674721A1 Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| 08/06/2008 | EP1953551A2 Prion protein ligands and methods of use |
| 08/06/2008 | EP1951743A1 Hepatitis c virus inhibitors |
| 08/06/2008 | EP1951276A1 Oligopeptides and their use |
| 08/06/2008 | CN101238142A Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
| 08/06/2008 | CN101235078A Method for generating amido bond |
| 08/05/2008 | US7408022 Cell permeable peptides; inhibit NF-kB activation; inhibit anti-apoptotic processes in cancer cells to promote tumor cell death |
| 08/05/2008 | US7407982 Polyoxyethylene glycol conjugates mean the drug is eliminated almost completely through the kidneys; bioavailability; anticoagulants |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | CA2167087C Peptides for neutralizing the toxicity of lipid a |
| 07/31/2008 | WO2008090944A1 Spiro-ring compound |
| 07/31/2008 | WO2008057875A3 Inhibitors of hepatitis c virus |
| 07/31/2008 | WO2008042634A3 Isotopically labeled trapping agent and method for identifying reactive metabolites |
| 07/31/2008 | WO2007077201A9 Piperazine compounds with a herbicidal action |
| 07/31/2008 | US20080182889 Prodrugs of excitatory amino acids |
| 07/31/2008 | US20080182798 Novel effectors of dipeptidyl peptidase IV |
| 07/31/2008 | DE102007002726A1 Neue Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel New cascade polymer complexes, process for their preparation and pharmaceutical compositions containing them |
| 07/30/2008 | EP1950224A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950223A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1948678A1 Compounds for enzyme inhibition |
| 07/30/2008 | EP1948212A2 Treatment of dry eye |
| 07/30/2008 | EP1648924B1 Dipeptide transglutaminase inhibitors and methods of using the same |
| 07/30/2008 | CN101233148A Macrocyclic peptides as HCV NS3 protease inhibitors |
| 07/30/2008 | CN101233147A Macrocyclic inhibitors of hepatitis c virus |
| 07/30/2008 | CN101233146A Inhibitors of cancer cell, t-cell and keratinocyte proliferation |
| 07/30/2008 | CN101233137A Macrocylic inhibitors of hepatitis c virus |
| 07/30/2008 | CN101232896A Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 07/30/2008 | CN101230089A Solid-phase synthesis of glycyl histidyl lycine |
| 07/29/2008 | US7405280 assaying the activity of TAFI (Thrombin Activatable Fibrinolysis inhibitor) in a blood sample; e.g. 3-chloro-p-tolylazoformylphenylalanylarginine |
| 07/29/2008 | US7405268 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/29/2008 | US7405267 Fermenting and isolating glycopeptide antibiotic using synthetic absorbent; bactericides |